Phase Ib Dose-Escalation Study of the Selective, Noncovalent, Reversible Bruton’s Tyrosine Kinase Inhibitor Vecabrutinib in B-cell Malignancies
John N. Allan, Javier Pinilla‐Ibarz, Douglas E. Gladstone,Krish Patel, Jeff P. Sharman,William G. Wierda, Michael Y. Choi, Susan O’Brien, Mazyar Shadman, Matthew S. Davids, John M. Pagel,Habte Yimer,Renee Ward, Gary D Acton,Pietro Taverna, Daniel L. Combs, Judith A. Fox, Richard R. Furman,Jennifer R. Brown Haematologica（2021）
AI 理解论文
溯源树
样例
